Counsyl Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
650
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$406M
Counsyl General Information
Description
Developer of a genomics and DNA screening technology platform intended to offer people access to information about their bodies. The company's platform uses custom-built robots to process blood and saliva samples working alongside a team of scientists and engineers to simultaneously analyze various DNA samples with precision, accuracy, and unparalleled efficiency, enabling individuals to understand their DNA and how it can impact important health decisions.
Contact Information
Website
www.counsyl.comCorporate Office
- 180 Kimball Way
- South San Francisco, CA 94080
- United States
Corporate Office
- 180 Kimball Way
- South San Francisco, CA 94080
- United States
Counsyl Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 31-Jul-2018 | $406M | Completed | Generating Revenue | ||
| 7. Debt - General | 06-Nov-2017 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 01-Aug-2015 | Completed | Generating Revenue | |||
| 5. Debt - General | 01-Aug-2015 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 08-May-2014 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 24-Aug-2012 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 16-Mar-2010 | $36.1M | $43.6M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 13-Apr-2009 | $7.5M | $7.5M | Completed | Startup |
Counsyl Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 7,138,317 | $0.001000 | 8% | $5.05 | $5.05 | 1x | $5.05 | 34.22% |
| Series A | 1,752,337 | $0.001000 | 8% | $4.28 | $4.28 | 1x | $4.28 | 8.4% |
Counsyl Comparisons
Industry
Financing
Details
Counsyl Competitors (34)
One of Counsyl’s 34 competitors is Dante Labs, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dante Labs | Formerly VC-backed | New York, NY | ||||
| Ambry Genetics | Formerly PE-Backed | Aliso Viejo, CA | ||||
| BGI Genomics | Formerly VC-backed | Shenzhen, China | ||||
| Admera Health | Venture Capital-Backed | South Plainfield, NJ | ||||
| Vizgen | Venture Capital-Backed | Cambridge, MA |
Counsyl Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Counsyl Patents
Counsyl Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240203521-A1 | Evaluation and improvement of genetic screening tests using receiver operating characteristic curves | Pending | 06-Sep-2017 | ||
| US-12020779-B1 | Noninvasive prenatal screening using dynamic iterative depth optimization with depth-scaled variance determination | Active | 06-Sep-2017 | ||
| CA-3059865-A1 | Systems and methods for performing and optimizing performance of dna-based noninvasive prenatal screens | Pending | 17-Apr-2017 | ||
| US-20180216253-A1 | Sequencing library preparation in small well format | Inactive | 31-Jan-2017 | ||
| US-20180214880-A1 | Automatic diagnostic laboratory and laboratory information management system for high throughput and device for removing microplate lids and methods of using the same | Active | 31-Jan-2017 | B01L9/50 |
Counsyl Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Counsyl Former Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aarin Capital Partners | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| ESO Fund | Secondary Buyer | Minority | ||
| Felicis | Venture Capital | Minority |
Counsyl FAQs
-
When was Counsyl founded?
Counsyl was founded in 2007.
-
Where is Counsyl headquartered?
Counsyl is headquartered in South San Francisco, CA.
-
What is the size of Counsyl?
Counsyl has 650 total employees.
-
What industry is Counsyl in?
Counsyl’s primary industry is Biotechnology.
-
Is Counsyl a private or public company?
Counsyl is a Private company.
-
What is the current valuation of Counsyl?
The current valuation of Counsyl is .
-
What is Counsyl’s current revenue?
The current revenue for Counsyl is .
-
How much funding has Counsyl raised over time?
Counsyl has raised $214M.
-
Who are Counsyl’s investors?
Aarin Capital Partners, , , ESO Fund, and Felicis are 5 of 21 investors who have invested in Counsyl.
-
Who are Counsyl’s competitors?
Dante Labs, Ambry Genetics, BGI Genomics, Admera Health, and Vizgen are some of the 34 competitors of Counsyl.
-
When was Counsyl acquired?
Counsyl was acquired on 31-Jul-2018.
-
Who acquired Counsyl?
Counsyl was acquired by Myriad Genetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
